Septarna Inc. SEPN
$35.76
▲ +5.64% 24H
About
Septerna Inc. is a clinical-stage biotechnology company specializing in the discovery and development of oral small molecule therapies targeting G protein-coupled receptors (GPCRs). Powered by its proprietary Native Complex Platform, the company unlocks challenging GPCR targets to create novel medicines for patients wi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees130
TickerSEPN
Statistics
Market Cap$1.61B
Revenue (TTM)$46.0M
Net Income-$48.9M
Net Margin-106.4%
EPS$-1.10
P/E-30.91
P/S19.01
P/B3.57
EV/EBITDA-15.76
ROE-9.3%
Dividend Yield—
Price$35.76
Data: Twelve Data · Revenue = mcap / P/S